Tirzepatide, this innovative medication, is sparking considerable interest in the scientific community. Originally intended as a treatment for adult-onset diabetes, this drug has unexpectedly demonstrated significant results regarding fat loss. Clinical trials suggest that tirzepatide, acting through a dual mechanism targeting the incretin hormones

Tirzepatide, this innovative medication, is creating considerable interest within the medical community. It works differently from common diabetes medications, targeting two receptors involved in sugar regulation and hunger . Initial research have demonstrated significant efficacy in reducing blood glucose in individuals with diabetes of the second